'I'm from farmer family...': Vaccine-maker Bharat Biotech's MD on controversy

Video Credit: HT Digital Content
Published on January 4, 2021 - Duration: 08:59s

'I'm from farmer family...': Vaccine-maker Bharat Biotech's MD on controversy

Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella, addressed a virtual conference amid doubts from some quarters regarding approval of the vaccine developed by the Indian company.

On January 3, the Drugs Controller General of India (DCGI) had allowed emergency use of Bharat Biotech's Covaxin and the Oxford-AstraZeneca vaccine being manufactured in India by the Serum Institute of India as 'Covishield'.

While listing his company's achievements and dismissing doubts regarding Covaxin's efficacy, Ella claimed that Indian companies and scientists are unjustly targeted.

He added that Bharat Biotech is the only company in the world to have a BSL3 production facility.

Watch the full video for more.


You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions

Related news from verified sources

Even as the countryโ€™s first indigenous Covid-19 vaccine Covaxin has received Emergency Use Authorisation (EUA) from the countryโ€™s drug regulatory...
on January 4, 2021 • IndiaTimes

Bharat Biotech founder and chairman Dr Krishna Ella on Monday lashed out at detractors who criticised the speed at which emergency use authorisation (EUA) was...
on January 4, 2021 • IndiaTimes

Vaccine maker Bharat Biotech commenced dispatches of indigenous Covid-19 vaccine Covaxin on Wednesday morning with the first lot of the vaccine doses being flown...
on January 13, 2021 • IndiaTimes

Related videos from verified sources

Vaccine minister reveals uncle died from coronavirus last week waiting for first jab 01:12
Video credit: Yahoo News - Published on January 26, 2021 

Family begs for vaccine for 93-year-old WWII veteran 02:30
Video credit: 7News - The Denver Channel - Published on January 26, 2021 

Moderna vaccine should work against UK and South Africa COVID variants 03:13
Video credit: Euronews English - Published on January 25, 2021 

You might like